MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

16 Jun 2021 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company's joint venture, Aleor Dermaceuticals has received US Food and Drug Administration (USFDA) Final Approval for Testosterone Topical Solution USP, 30 mg per pump actuation. The company has enclosed a press release on 16th June 2021, regarding the same.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..